Promoted Companies
SORT BY:
VolitionRX Ltd (VNRX)
| Total paid for Promotions this month: | $0 | ||
| E-mails this Month: | 1 | ||
| Estimated Volume Generated: | $0 | ||
| Research Report on VNRX: | Click to see | ||
| * The information presented is based on information for Sep , 2014 | |||
New Alert >> VNRX << Tests the $5 dollar range! Sep 24, 2014 12:16
HOME
ABOUT US
TRADE IDEAS
PENNY STOCK ARTICLES
DAILY NEWS
Call Us: 561-807-6350 | Email Us: info@smallcapstockplays.com
Small Cap Investors,
Last weeks Spotlight VolitionRx Limited (OTCQB: VNRX) has been testing the $5 dollar range up 25%.
VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer.
...read more
| Promoter: | SmallCapStockPlays | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VNRX | Unknown compensation | UNKNOWN |
| Max Profit: 1.59 % | Gain at close: Pending |
VolitionRx Ltd. (VNRX) - Tip of the Week Jun 22, 2014 18:02
VolitionRx Ltd. (VNRX)
VolitionRx Ltd. is a life sciences company focused on bringing to market its inexpensive, accurate, and scalable cancer detection blood tests. The company intends to use its NuQ® suite of products to fill a looming void in cancer diagnostic testing, for which there currently is only one blood test in common clinical use.
View The Full Company Profile
Armco Metals Holdings, Inc.
...read more
| Promoter: | Tip.us | Paying Party: | No Third Party |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VNRX | $26,050 | UNKNOWN |
| Max Profit: 0.00 % | Gain at close: Pending |
VolitionRx Ltd. (VNRX) - Tip of the Week Mar 10, 2014 08:30
VolitionRx Ltd. (VNRX)
VolitionRx Ltd. is a life sciences company focused on bringing to market its inexpensive, accurate, and scalable cancer detection blood tests. The company intends to use its NuQR suite of products to fill a looming void in cancer diagnostic testing, for which there currently is only one blood test in common clinical use.
View The Full Company Profile
Actinium Pharmaceuticals, Inc. (ATNM) Boston
...read more
| Promoter: | Tip.us | Paying Party: | No Third Party |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VNRX | $26,050 | UNKNOWN |
| Max Profit: 3.23 % | Gain at close: Pending |
It Gets $5M Milestone Payment, Eligible to Receive Up to an... Dec 02, 2013 09:21
It Gets $5M Milestone Payment, Eligible to Receive Up to an Additional $95M in Payments
Cell Therapeutics, Inc. (CTIC)
CTIC reported that it has received a $5 million milestone payment from Teva Pharmaceutical Industries Ltd. related to the achievement of a sales milestone for TRISENOXR) (arsenic trioxide).
TRISENOX was acquired from CTIC by Cephalon, Inc., which was subsequently acquired by Teva.
The milestone was paid
...read more
| Promoter: | Crweselect.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VNRX | Unknown compensation | UNKNOWN |
| Max Profit: 0.00 % | Gain at close: Pending |
It Gets $5M Milestone Payment, Eligible to Receive Up to an... Dec 02, 2013 08:55
It Gets $5M Milestone Payment, Eligible to Receive Up to an Additional $95M in Payments
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Cell Therapeutics, Inc. (CTIC)
CTIC reported that it has received a $5 million milestone payment from Teva Pharmaceutical Industries Ltd. related to the achievement of a sales milestone for TRISENOXR) (arsenic trioxide).
TRISENOX was acquired
...read more
| Promoter: | pennyomega.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VNRX | Unknown compensation | UNKNOWN |
| Max Profit: 0.00 % | Gain at close: Pending |
It Gets $5M Milestone Payment, Eligible to Receive Up to an... Dec 02, 2013 08:26
It Gets $5M Milestone Payment, Eligible to Receive Up to an Additional $95M in Payments
Cell Therapeutics, Inc. (CTIC)
CTIC reported that it has received a $5 million milestone payment from Teva Pharmaceutical Industries Ltd. related to the achievement of a sales milestone for TRISENOXR) (arsenic trioxide).
TRISENOX was acquired from CTIC by Cephalon, Inc., which was subsequently acquired by Teva.
The milestone was paid
...read more
| Promoter: | Crwefinance.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VNRX | Unknown compensation | UNKNOWN |
| Max Profit: 0.00 % | Gain at close: Pending |